Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( (HK:6821) ) has shared an announcement.
Asymchem Laboratories (Tianjin) Co., Ltd. announced that its board of directors will convene on August 25, 2025, to review and approve the interim financial results for the first half of the year and discuss potential dividend payments. This meeting is significant as it will provide insights into the company’s financial health and strategic decisions, impacting stakeholders and potentially influencing its market position.
The most recent analyst rating on (HK:6821) stock is a Buy with a HK$55.23 price target. To see the full list of analyst forecasts on Asymchem Laboratories (Tianjin) Co., Ltd. Class H stock, see the HK:6821 Stock Forecast page.
More about Asymchem Laboratories (Tianjin) Co., Ltd. Class H
Asymchem Laboratories (Tianjin) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company focuses on providing comprehensive services in drug development and manufacturing, catering to a global market.
Average Trading Volume: 855,704
Technical Sentiment Signal: Buy
Current Market Cap: HK$41.51B
See more insights into 6821 stock on TipRanks’ Stock Analysis page.